These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3938729)

  • 1. [Double-stimulation tests with an analogue of LH-RH in polycystic ovarian syndrome].
    Zhou JP
    Zhonghua Fu Chan Ke Za Zhi; 1985 Nov; 20(6):344-8, 383. PubMed ID: 3938729
    [No Abstract]   [Full Text] [Related]  

  • 2. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
    Calogero AE; Macchi M; Montanini V; Mongioi A; Maugeri G; Vicari E; Coniglione F; Sipione C; D'Agata R
    J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Initial experiences and results with the GnRH agonist D-TRP 6 LHRH (decapeptyl-CR) in the treatment of polycystic ovary syndrome].
    Freude G; Artner B; Leodolter S
    Arch Gynecol Obstet; 1989; 245(1-4):988-90. PubMed ID: 2529831
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma follicle-stimulating and luteinizing hormones and the macrosopic characteristics of the ovaries in patients with stein-leventhal syndrome. Response to LH-RH in Stein-Leventhal syndrome.
    Valkov IM; Dokumov I
    Endocrinologie; 1977; 15(1):55-8. PubMed ID: 322249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the best treatment for women with polycystic ovarian syndrome and high LH/FSH ratio? A comparison among in vitro fertilization with GnRH agonist, GnRH antagonist and in vitro maturation.
    Ganor-Paz Y; Friedler-Mashiach Y; Ghetler Y; Hershko-Klement A; Berkovitz A; Gonen O; Shulman A; Wiser A
    J Endocrinol Invest; 2016 Jul; 39(7):799-803. PubMed ID: 26797707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abolishment of the positive feedback mechanism: a criterion for temporary medical hypophysectomy by LH-RH agonist.
    Shadmi AL; Lunenfeld B; Bahari C; Kokia E; Pariente C; Blankstein J
    Gynecol Endocrinol; 1987 Mar; 1(1):1-11. PubMed ID: 2972166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Menopausal flushes: effect of pituitary gonadotropin desensitization by a potent luteinizing hormone- releasing factor agonist.
    Casper RF; Yen SS
    J Clin Endocrinol Metab; 1981 Nov; 53(5):1056-8. PubMed ID: 6793613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal luteinizing hormone response patterns to synthetic gonadotrophin releasing hormone in patients with polycystic ovarian syndrome.
    Katz M; Carr PJ
    J Endocrinol; 1976 Aug; 70(2):163-71. PubMed ID: 787466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is increased secretion of LH after LHRH administration a reliable indicator of polycystic ovary syndrome?].
    Steck T; Petraki S; Baseler C; Albert PJ; Wernze H
    Gynakol Rundsch; 1991; 31 Suppl 2():328-31. PubMed ID: 1790969
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute N-methyl-D,L-aspartate administration stimulates the luteinizing hormone releasing hormone pulse generator in the ovine fetus.
    Bettendorf M; de Zegher F; Albers N; Hart CS; Kaplan SL; Grumbach MM
    Horm Res; 1999; 51(1):25-30. PubMed ID: 10095166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further evidence concerning catecholamine metabolism in polycystic ovary syndrome following Gn-RH administration.
    Yoshino K; Takahashi K; Nishigaki A; Eda Y; Kitao M
    Int J Fertil; 1992; 37(2):111-4. PubMed ID: 1349592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome.
    Barnes RB; Rosenfield RL; Burstein S; Ehrmann DA
    N Engl J Med; 1989 Mar; 320(9):559-65. PubMed ID: 2521688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of precocious puberty with an LH-RH agonist (D-TRP6-LH-RH delayed-release microcapsules)].
    Canlorbe P; Chaussain JL; Lahlou N; Roger M; Toublanc JE; Job JC
    Bull Acad Natl Med; 1988 Nov; 172(8):1091-8. PubMed ID: 2977732
    [No Abstract]   [Full Text] [Related]  

  • 15. Stimulation of LH fragments with reduced bioactivity following GnRH agonist administration in women.
    Meldrum DR; Tsao Z; Monroe SE; Braunstein GD; Sladek J; Lu JK; Vale W; Rivier J; Judd HL; Chang RJ
    J Clin Endocrinol Metab; 1984 Apr; 58(4):755-7. PubMed ID: 6365947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reaction of follicle-stimulating and luteinizing hormone to synthetic luteinizing hormone in the Stein-Leventhal syndrome].
    Vulkov I
    Akush Ginekol (Sofiia); 1976; 15(6):459-62. PubMed ID: 797267
    [No Abstract]   [Full Text] [Related]  

  • 17. Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study.
    Graña-Barcia M; Liz-Lestón J; Lado-Abeal J
    Fertil Steril; 2005 May; 83(5):1466-72. PubMed ID: 15866586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of pharmacological hypogonadotropism using gonadotropin-releasing hormone agonists in patients undergoing controlled ovarian stimulation.
    Lindner C; Braendle W; Lichtenberg V; Bettendorf G
    Gynecol Obstet Invest; 1990; 29(2):132-9. PubMed ID: 2139863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empty follicle syndrome in perimenopausal patients.
    Greb R; van Uem JF; Bauer T
    Fertil Steril; 1993 May; 59(5):1141-2. PubMed ID: 8486189
    [No Abstract]   [Full Text] [Related]  

  • 20. The Stein-Leventhal syndrome: a neuropituitary disorder.
    Scaglia H; Medina M; Gual C; Cabeza M; Pérez-Palacios G
    Fertil Steril; 1976 Mar; 27(3):243-9. PubMed ID: 767160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.